Literature DB >> 18208578

Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.

H B T Christesen1, K Brusgaard, H Beck Nielsen, B Brock Jacobsen.   

Abstract

OBJECTIVE: Adult-onset non-insulinoma persistent hyperinsulinaemic hypoglycaemia (NI-PHH) and the variant NI-pancreatogenous hypoglycaemia syndrome (NIPHS) are genetically unexplained diseases, without reports of hypoglycaemia unawareness or familial inheritance. DESIGN AND PATIENTS: In a prospective 8-year follow-up, a boy (i) with NI-PHH since age 14 years, his mother (ii), the mother's brother (iii) and his daughter (iv) were studied.
RESULTS: Patient (i) was characterized by especially postprandial hypoglycaemia down to 1.6 mmol/l and pronounced variability in diazoxide need with obesity; (ii) had asymptomatic blood glucose down to 2.9 mmol/l, but a severe hypoglycaemic postprandial attack after a slimming diet; (iii) had moderate hypoglycaemic symptoms since childhood and need of frequent eating; and (iv) was asymptomatic until a hypoglycaemic accident in the age of 24. After a slimming diet, symptomatic fasting, but especially postprandial hypoglycaemia occurred (blood glucose 1.9 mmol/l after 19 h fasting; 1.6 mmol/l 3.5 h after OGTT). By CT-scan/endoscopic ultrasound in three of the individuals, insulinoma could not be detected. In all four individuals, an activating glucokinase (GCK) mutation A456V was found. No mutations were found in the ABCC8 or KCNJ11 genes. The patients responded to treatment with diazoxide or octreotide long acting release.
CONCLUSION: This is the first report to highlight a genetic cause to adult-onset NI-PHH/NIPHS. The activating GCK mutation was dominantly inherited, but only after year-long follow-up and investigations, other family members were diagnosed symptomatic. Hypoglycaemia unawareness seems to be a prominent feature, but hypoglycaemic attacks occur after slimming, especially postprandially. PHH-GCK was medical responsive.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208578     DOI: 10.1111/j.1365-2265.2008.03184.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus.

Authors:  Khalid Hussain
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

2.  Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management.

Authors:  Benjamin G Challis; Andrew S Powlson; Ruth T Casey; Carla Pearson; Brian Y Lam; Marcella Ma; Deborah Pitfield; Giles S H Yeo; Edmund Godfrey; Heok K Cheow; V Krishna Chatterjee; Nicholas R Carroll; Ashley Shaw; John R Buscombe; Helen L Simpson
Journal:  Endocr Connect       Date:  2017-08-07       Impact factor: 3.335

3.  Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia.

Authors:  Marianne Geilswijk; Lise Lotte Andersen; Morten Frost; Klaus Brusgaard; Henning Beck-Nielsen; Anja Lisbeth Frederiksen; Dorte Møller Jensen
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-02-15

Review 4.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

Review 5.  Towards enhanced understanding of idiopathic ketotic hypoglycemia: a literature review and introduction of the patient organization, Ketotic Hypoglycemia International.

Authors:  Danielle Drachmann; Erica Hoffmann; Austin Carrigg; Beccie Davis-Yates; Valerie Weaver; Paul Thornton; David A Weinstein; Jacob S Petersen; Pratik Shah; Henrik Thybo Christesen
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

6.  Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.

Authors:  Benjamin G Challis; Julie Harris; Alison Sleigh; Iona Isaac; Steve M Orme; Nandini Seevaratnam; Ketan Dhatariya; Helen L Simpson; Robert K Semple
Journal:  Clin Endocrinol (Oxf)       Date:  2014-07-02       Impact factor: 3.478

Review 7.  Hypoglycaemia related to inherited metabolic diseases in adults.

Authors:  Claire Douillard; Karine Mention; Dries Dobbelaere; Jean-Louis Wemeau; Jean-Marie Saudubray; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2012-05-15       Impact factor: 4.123

8.  99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.

Authors:  Anna Sowa-Staszczak; Małgorzata Trofimiuk-Müldner; Agnieszka Stefańska; Monika Tomaszuk; Monika Buziak-Bereza; Aleksandra Gilis-Januszewska; Agata Jabrocka-Hybel; Bogusław Głowa; Maciej Małecki; Tomasz Bednarczuk; Grzegorz Kamiński; Aldona Kowalska; Renata Mikołajczak; Barbara Janota; Alicja Hubalewska-Dydejczyk
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

9.  Glucokinase activating mutation causing hypoglycaemia diagnosed late in adult who fasts for Ramadhan.

Authors:  Wann Jia Loh; Lily Mae Dacay; Clara Si Hua Tan; Su Fen Ang; Fabian Yap; Su Chi Lim; Joan Khoo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.